GBD 2021 Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. Lancet. 2024;404:1199–226.
Aslam B, Asghar R, Muzammil S, et al. AMR and sustainable development goals: at a crossroads. Glob Health. 2024;20:73.
Tang KWK, Millar BC, Moore JE. Antimicrobial resistance (AMR). Br J Biomed Sci. 2023;80:11387.
Article PubMed PubMed Central Google Scholar
Allen L. Are we facing a noncommunicable disease pandemic? J Epidemiol Glob Health. 2017;7:5–9.
World Health Organization. Noncommunicable diseases. https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases. Accessed 12 May 2025.
Keenan K, Silva Corrêa J, Sringernyuang L, Nayiga S, Chandler CIR. The social burden of antimicrobial resistance: what is it, how can we measure it, and why does it matter? JAC Antimicrob Resist. 2025;7:dlae208.
Article PubMed PubMed Central Google Scholar
Ferrinho P, Viveiros M, Fronteira I. Antimicrobial resistance, society and environment: a glocal syndemic. One Health. 2023;16:100512.
Article CAS PubMed PubMed Central Google Scholar
Trivedi U, Parameswaran S, Armstrong A et al. Prevalence of multiple antibiotic resistant infections in diabetic versus nondiabetic wounds. J Pathog. 2014;2014:173053.
PubMed PubMed Central Google Scholar
Gupta V, Satlin M, Yu K, et al. Incidence and prevalence of antimicrobial resistance in outpatients with cancer: a multicentre, retrospective, cohort study. Lancet Oncol. 2025;26:620–8.
Article CAS PubMed Google Scholar
Murray CJL, Ikuta KS, Sharara F, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629–55.
Palermos D, Pavi E, Halvatsiotis P, Mangoulia P, Sergentanis T, Psaltopoulou T. Individual-based socioeconomic vulnerability and deprivation indices: a scoping review. Front Public Health. 2024;12:1403723.
Article PubMed PubMed Central Google Scholar
Braveman P. What are health disparities and health equity? We need to be clear. Public Health Rep. 2014;129(Suppl 2):5–8.
Article PubMed PubMed Central Google Scholar
A conceptual framework for action on the social determinants of health.https://www.who.int/publications/i/item/9789241500852. Accessed 12 May 2025.
Haque M, Islam T, Rahman N, McKimm J, Abdullah A, Dhingra S. Strengthening primary health-care services to help prevent and control long-term (chronic) non-communicable diseases in low- and middle-income countries. Risk Manag Healthc Policy. 2020;13:409–26.
Article PubMed PubMed Central Google Scholar
Ganatra S, Dani S, Kumar A, et al. Impact of social vulnerability on comorbid cancer and cardiovascular disease mortality in the United States. JACC CardioOncol. 2022;4:326–37.
Article PubMed PubMed Central Google Scholar
Dugani SB, Wood-Wentz CM, Mielke MM, Bailey KR, Vella A. Assessment of disparities in diabetes mortality in adults in US rural vs nonrural counties, 1999–2018. JAMA Netw Open. 2022;5:e2232318–e2232318.
Article PubMed PubMed Central Google Scholar
van Duin D, Paterson DL. Multidrug-resistant bacteria in the community: an update. Infect Dis Clin North Am. 2020;34:709–22.
Article PubMed PubMed Central Google Scholar
Alsan M, Kammili N, Lakshmi J, et al. Poverty and community-acquired antimicrobial resistance with extended-spectrum β-lactamase-producing organisms, hyderabad. India Emerg Infect Dis. 2018;24:1490–6.
Article CAS PubMed Google Scholar
Cooper LN, Beauchamp A, Ingle T, et al. Socioeconomic disparities and the prevalence of antimicrobial resistance. Clin Infect Dis. 2024;79:1346–53.
Article CAS PubMed PubMed Central Google Scholar
Mendenhall E, Kohrt BA, Logie CH, Tsai AC. Syndemics and clinical science. Nat Med. 2022;28:1359–62.
Article CAS PubMed Google Scholar
Singer M, Bulled N, Ostrach B, Mendenhall E. Syndemics and the biosocial conception of health. Lancet. 2017;389:941–50.
Singer M. A dose of drugs, a touch of violence, a case of AIDS, part 2: further conceptualizing the SAVA syndemic. Free Inq Creat Sociol. 2006;34:39–54.
Bulled N, Singer M. Conceptualizing COVID-19 syndemics: a scoping review. J Multimorb Comorb. 2024;14:26335565241249836.
Article PubMed PubMed Central Google Scholar
Hernandez Barrios Y, Perez Chacon D, Molina Gomez Y, et al. Using a syndemics perspective to (re)conceptualize vulnerability during the COVID-19 pandemic: a scoping review. Trop Med Infect Dis. 2024;9:189.
Article PubMed PubMed Central Google Scholar
McGowan VJ, Bambra C. COVID-19 mortality and deprivation: pandemic, syndemic, and endemic health inequalities. Lancet Public Health. 2022;7:e966–75.
Article PubMed PubMed Central Google Scholar
Xu, X, Shi Z, Zhou L, et al. Impact of COVID-19 on risks and deaths of non-communicable diseases in the Western Pacific region. Lancet Reg Health West Pac. 2023;43:100795.
Li R, Shen M, Yang Q, et al. Global diabetes prevalence in COVID-19 patients and contribution to COVID-19-related severity and mortality: a systematic review and meta-analysis. Diabetes Care. 2023;46:890–7.
Article CAS PubMed PubMed Central Google Scholar
Alyammahi SK, Abdin SM, Alhamad DW, Elgendy SM, Altell AT, Omar HA. The dynamic association between COVID-19 and chronic disorders: an updated insight into prevalence, mechanisms and therapeutic modalities. Infect Genet Evol. 2021;87:104647.
Article CAS PubMed Google Scholar
Miller MG, Terebuh P, Kaelber DC, Xu R, Davis PB. SARS-CoV-2 infection and new-onset type 2 diabetes among pediatric patients, 2020 to 2022. JAMA Netw Open. 2024;7:e2439444.
Article PubMed PubMed Central Google Scholar
Wang Z, Du Z, Zhu F. Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients. Diabetes Res Clin Pract. 2020;164: 108214.
Article CAS PubMed PubMed Central Google Scholar
World Health Organization. Pulse survey on continuity of essential health services during the COVID-19 pandemic: interim report, 27 August 2020 https://www.who.int/publications/i/item/WHO-2019-nCoV-EHS_continuity-survey-2020.1. Accessed 04 Jun 2025.
Khunti K, Prato S, Mathieu C, Kahn S, Gabbay R, Buse J. COVID-19, hyperglycemia, and new-onset diabetes. Diabetes Care. 2021;44:2645–55.
Article CAS PubMed PubMed Central Google Scholar
Liu E, Dean CA, Elder KT. Editorial: The impact of COVID-19 on vulnerable populations. Front Public Health. 2023;11:1267723.
Article PubMed PubMed Central Google Scholar
Abdul-Mutakabbir JC, Casey S, Jews V, et al. A three-tiered approach to address barriers to COVID-19 vaccine delivery in the Black community. Lancet Glob Health. 2021;9:e749–50.
Article CAS PubMed PubMed Central Google Scholar
Khazanchi R, Evans CT, Marcelin JR. Racism, not race, drives inequity across the COVID-19 continuum. JAMA Netw Open. 2020;3:e2019933–e2019933.
World Health Organization. Action against antimicrobial resis
Comments (0)